{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T20:12:23Z","timestamp":1793736743659,"version":"4.6.1"},"reference-count":30,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2011,2,1]],"date-time":"2011-02-01T00:00:00Z","timestamp":1296518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2011,2]]},"DOI":"10.1016\/j.atherosclerosis.2010.11.031","type":"journal-article","created":{"date-parts":[[2010,11,27]],"date-time":"2010-11-27T09:22:13Z","timestamp":1290849733000},"page":"480-485","source":"Crossref","is-referenced-by-count":31,"title":["Homocysteine is a determinant of ApoA-I and both are associated with ankle brachial index, in an Ambulatory Elderly Population"],"prefix":"10.1016","volume":"214","author":[{"given":"Rosa Maria","family":"Gu\u00e9ant-Rodriguez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosario","family":"Spada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maira","family":"Moreno-Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guido","family":"Anello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Bosco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Lagrost","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonino","family":"Romano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Elia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Louis","family":"Gu\u00e9ant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2010.11.031_bib0005","doi-asserted-by":"crossref","first-page":"e25","DOI":"10.1161\/CIRCULATIONAHA.107.187998","article-title":"Heart disease and stroke statistics\u20142008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee","volume":"117","author":"Rosamond","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2010.11.031_bib0010","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1093\/ije\/20.2.384","article-title":"Edinburgh Artery Study: prevalence of asymptomatic and symptomatic peripheral arterial disease in the general population","volume":"20","author":"Fowkes","year":"1991","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.atherosclerosis.2010.11.031_bib0015","doi-asserted-by":"crossref","first-page":"e463","DOI":"10.1161\/CIRCULATIONAHA.106.174526","article-title":"ACC\/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic)","volume":"113","author":"Hirsch","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2010.11.031_bib0020","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S0025-6196(11)61191-9","article-title":"Association of novel risk factors with the ankle brachial index in African American and non-Hispanic white populations","volume":"82","author":"Khawaja","year":"2007","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.atherosclerosis.2010.11.031_bib0025","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.jacc.2007.05.017","article-title":"Elevated levels of inflammation, d-dimer, and homocysteine are associated with adverse calf muscle characteristics and reduced calf strength in peripheral arterial disease","volume":"50","author":"McDermott","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.atherosclerosis.2010.11.031_bib0030","doi-asserted-by":"crossref","first-page":"85","DOI":"10.7326\/0003-4819-148-2-200801150-00003","article-title":"Biomarkers of inflammation and thrombosis as predictors of near-term mortality in patients with peripheral arterial disease: a cohort study","volume":"148","author":"Vidula","year":"2008","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.atherosclerosis.2010.11.031_bib0035","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1161\/01.CIR.85.1.30","article-title":"Lipoprotein profile in men with peripheral vascular disease. Role of intermediate density lipoproteins and apoprotein E phenotypes","volume":"85","author":"Senti","year":"1992","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2010.11.031_bib0040","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1001\/jama.285.19.2481","article-title":"Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease","volume":"285","author":"Ridker","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.atherosclerosis.2010.11.031_bib0045","first-page":"111","article-title":"Vascular pathology of homocysteinemia: implications for the pathogenesis of arteriosclerosis","volume":"56","author":"McCully","year":"1969","journal-title":"Am J Pathol"},{"key":"10.1016\/j.atherosclerosis.2010.11.031_bib0050","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.thromres.2003.08.015","article-title":"Serum homocysteine and severity of coronary artery disease","volume":"111","author":"Wald","year":"2003","journal-title":"Thromb Res"},{"key":"10.1016\/j.atherosclerosis.2010.11.031_bib0055","doi-asserted-by":"crossref","first-page":"17","DOI":"10.2174\/138920007779315008","article-title":"Hyperhomocysteinaemia: a critical review of old and new aspects","volume":"8","author":"Herrmann","year":"2007","journal-title":"Curr Drug Metab"},{"key":"10.1016\/j.atherosclerosis.2010.11.031_bib0060","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1111\/j.1538-7836.2007.02535.x","article-title":"Left ventricular systolic dysfunction is an independent predictor of homocysteine in angiographically documented patients with or without coronary artery lesions","volume":"5","author":"Gueant-Rodriguez","year":"2007","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.atherosclerosis.2010.11.031_bib0065","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1111\/j.1538-7836.2005.01364.x","article-title":"Mechanisms of homocysteine-induced atherothrombosis","volume":"3","author":"Lentz","year":"2005","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.atherosclerosis.2010.11.031_bib0070","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.ejvs.2009.05.007","article-title":"Homocysteine and peripheral arterial disease: systematic review and meta-analysis","volume":"38","author":"Khandanpour","year":"2009","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.atherosclerosis.2010.11.031_bib0075","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.freeradbiomed.2008.11.002","article-title":"Homocysteine and inflammation as main determinants of oxidative stress in the elderly","volume":"46","author":"Ventura","year":"2009","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.atherosclerosis.2010.11.031_bib0080","doi-asserted-by":"crossref","first-page":"E116","DOI":"10.1161\/01.CIR.101.12.e116","article-title":"Hyperhomocyst(e)inemia is a risk factor for arterial endothelial dysfunction in humans","volume":"101","author":"Woo","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2010.11.031_bib0085","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1161\/01.RES.0000242559.42077.22","article-title":"Hyperhomocysteinemia decreases circulating high-density lipoprotein by inhibiting apolipoprotein A-I Protein synthesis and enhancing HDL cholesterol clearance","volume":"99","author":"Liao","year":"2006","journal-title":"Circ Res"},{"key":"10.1016\/j.atherosclerosis.2010.11.031_bib0090","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1161\/01.RES.0000204825.66410.0b","article-title":"Elevated homocysteine reduces apolipoprotein A-I expression in hyperhomocysteinemic mice and in males with coronary artery disease","volume":"98","author":"Mikael","year":"2006","journal-title":"Circ Res"},{"key":"10.1016\/j.atherosclerosis.2010.11.031_bib0095","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1093\/aje\/kwi167","article-title":"Ankle-brachial index and subclinical cardiac and carotid disease: the multi-ethnic study of atherosclerosis","volume":"162","author":"McDermott","year":"2005","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.atherosclerosis.2010.11.031_bib0100","doi-asserted-by":"crossref","first-page":"21930","DOI":"10.1073\/pnas.0811794106","article-title":"Vitamin B12 deficiency reduces proliferation and promotes differentiation of neuroblastoma cells and up-regulates PP2A, proNGF, and TACE","volume":"106","author":"Battaglia-Hsu","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.atherosclerosis.2010.11.031_bib0105","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1160\/TH05-04-0262","article-title":"Association of MTRRA66G polymorphism (but not of MTHFR C677T and A1298C, MTRA2756G, TCN C776G) with homocysteine and coronary artery disease in the French population","volume":"94","author":"Gueant-Rodriguez","year":"2005","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.atherosclerosis.2010.11.031_bib0110","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1093\/clinchem\/41.5.717","article-title":"Direct measurement of high-density lipoprotein cholesterol in serum with polyethylene glycol-modified enzymes and sulfated alpha-cyclodextrin","volume":"41","author":"Sugiuchi","year":"1995","journal-title":"Clin Chem"},{"key":"10.1016\/j.atherosclerosis.2010.11.031_bib0115","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","article-title":"Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge","volume":"18","author":"Friedewald","year":"1972","journal-title":"Clin Chem"},{"key":"10.1016\/j.atherosclerosis.2010.11.031_bib0120","doi-asserted-by":"crossref","first-page":"19058","DOI":"10.1074\/jbc.271.32.19058","article-title":"Opposite effects of cholesteryl ester transfer protein and phospholipid transfer protein on the size distribution of plasma high density lipoproteins. Physiological relevance in alcoholic patients","volume":"271","author":"Lagrost","year":"1996","journal-title":"J Biol Chem"},{"issue":"Suppl. 1","key":"10.1016\/j.atherosclerosis.2010.11.031_bib0125","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.ejvs.2006.09.024","article-title":"Inter-Society Consensus for the Management of peripheral arterial disease (TASC II)","volume":"33","author":"Norgren","year":"2007","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.atherosclerosis.2010.11.031_bib0130","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1161\/CIRCULATIONAHA.107.719369","article-title":"Symptomatic peripheral arterial disease in women: nontraditional biomarkers of elevated risk","volume":"117","author":"Pradhan","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2010.11.031_bib0135","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1021\/bi0518040","article-title":"Inhibition of apolipoprotein AI gene expression by tumor necrosis factor alpha: roles for MEK\/ERK and JNK signaling","volume":"45","author":"Beers","year":"2006","journal-title":"Biochemistry"},{"key":"10.1016\/j.atherosclerosis.2010.11.031_bib0140","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1056\/NEJMoa055227","article-title":"Homocysteine lowering and cardiovascular events after acute myocardial infarction","volume":"354","author":"Bonaa","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.atherosclerosis.2010.11.031_bib0145","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1056\/NEJMoa060900","article-title":"Homocysteine lowering with folic acid and B vitamins in vascular disease","volume":"354","author":"Lonn","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.atherosclerosis.2010.11.031_bib0150","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1093\/jn\/135.6.1393","article-title":"Daily supplementation with (n-3) PUFAs, oleic acid, folic acid, and vitamins B-6 and E increases pain-free walking distance and improves risk factors in men with peripheral vascular disease","volume":"135","author":"Carrero","year":"2005","journal-title":"J Nutr"}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915010009706?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915010009706?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,14]],"date-time":"2020-06-14T03:55:54Z","timestamp":1592106954000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915010009706"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,2]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,2]]}},"alternative-id":["S0021915010009706"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2010.11.031","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2011,2]]}}}